Cowealth Medical China Co.,Ltd. (SHA:603122)

Cowealth Medical China Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	127.78	106.47	260.84	197.89	326.86	146.6
Short-Term Investments	-	42.98	-	-	-	-
Trading Asset Securities	-	-	-	-	10	-
Cash & Short-Term Investments	127.78	149.44	260.84	197.89	336.86	146.6
Cash Growth	-57.33%	-42.71%	31.81%	-41.25%	129.78%	-40.66%
Accounts Receivable	750.27	716.33	746.93	758.84	747.95	557.35
Other Receivables	0.92	1.58	2.15	7.65	4.77	6.89
Receivables	751.19	717.91	749.08	766.49	752.72	564.24
Inventory	164.09	172.64	201.88	196.87	204.82	178.86
Other Current Assets	90.15	84.29	79.18	93.54	116.95	80.14
Total Current Assets	1,133	1,124	1,291	1,255	1,411	969.85
Property, Plant & Equipment	149.51	152.92	118.95	118.53	81.98	88.27
Long-Term Investments	13.76	24.5	-	-	-	-
Other Intangible Assets	6.19	7	7.48	7.89	1.81	0.94
Long-Term Deferred Tax Assets	48.62	44.78	29.99	34.3	31.79	29.06
Long-Term Deferred Charges	18.41	18.73	21.9	17.78	13.82	23.43
Other Long-Term Assets	54.9	55.26	22.63	24	15.63	5.96
Total Assets	1,425	1,429	1,494	1,461	1,559	1,121

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	320.45	266.4	224.12	167.67	240.09	127.8
Accrued Expenses	9.99	11.39	14.85	43.4	40.11	37.82
Short-Term Debt	27.8	57.07	46.27	53.92	51.31	97.64
Current Portion of Long-Term Debt	-	1.48	2.22	8.84	8.69	10.15
Current Portion of Leases	-	0.72	1.34	2.51	3.44	3.41
Current Income Taxes Payable	-	1.15	5.11	7.08	14.56	13.99
Current Unearned Revenue	0.63	0.49	1.61	1.14	2.04	9.12
Other Current Liabilities	24.25	28.19	23.18	1.16	1.32	1.67
Total Current Liabilities	383.12	366.88	318.7	285.73	361.55	301.61
Long-Term Debt	1.1	1.9	-	2.18	10.84	11.99
Long-Term Leases	0.35	0.12	0.74	3.5	5.71	7.91
Other Long-Term Liabilities	-	-	-	1.08	2.38	3.28
Total Liabilities	384.57	368.9	319.44	292.49	380.49	324.78

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	398.05	398.05	398.05	398.05	398.05	298.54
Additional Paid-In Capital	596.74	596.74	596.62	596.65	596.65	336.1
Retained Earnings	77.87	85.37	170.76	167.08	179.6	168.53
Comprehensive Income & Other	-34.87	-22.28	6.03	5.02	3.44	-7.33
Total Common Equity	1,038	1,058	1,171	1,167	1,178	795.83
Minority Interest	2.25	1.74	3.16	2.11	0.83	-0.07
Shareholders' Equity	1,040	1,060	1,175	1,169	1,179	795.77
Total Liabilities & Equity	1,425	1,429	1,494	1,461	1,559	1,121

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	29.25	61.29	50.57	70.96	80	131.1
Net Cash (Debt)	98.54	88.16	210.28	126.93	256.86	15.5
Net Cash Growth	-62.03%	-58.08%	65.66%	-50.58%	1556.84%	-88.19%
Net Cash Per Share	0.23	0.21	0.53	0.32	0.68	0.05
Filing Date Shares Outstanding	335.67	398.05	398.05	398.05	398.05	398.05
Total Common Shares Outstanding	335.67	398.05	398.05	398.05	398.05	298.54
Working Capital	750.09	757.41	972.28	969.07	1,050	668.24
Book Value Per Share	3.09	2.66	2.94	2.93	2.96	2.67
Tangible Book Value	1,032	1,051	1,164	1,159	1,176	794.89
Tangible Book Value Per Share	3.07	2.64	2.92	2.91	2.95	2.66
Buildings	-	127.69	127.69	122.07	80.07	78.78
Machinery	-	47.89	57.95	67.42	83.41	86.82
Construction In Progress	-	39.51	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error